{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:21:00Z","timestamp":1768620060135,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K07799"],"award-info":[{"award-number":["JP21K07799"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jvacx.2024.100558","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T07:22:55Z","timestamp":1726644175000},"page":"100558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of Bacille Calmette-Gu\u00e9rin vaccination on the therapeutic schedule of infantile epileptic spasms syndrome: A 25-year Japanese single-center survey"],"prefix":"10.1016","volume":"20","author":[{"given":"Hikaru","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3496-4222","authenticated-orcid":false,"given":"Takeshi","family":"Matsushige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Hoshide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100558_b0005","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1016\/j.vaccine.2022.05.055","article-title":"Characteristics and incidence of vaccine adverse events after Bacille Calmette-Guerin vaccination: a national surveillance study in Japan from 2013 to 2017","volume":"40","author":"Okuno","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100558_b0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7883\/yoken.JJID.2007.331","article-title":"Historical review of BCG vaccine in Japan","volume":"60","author":"Yamamoto","year":"2007","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100558_b0015","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/epi.17239","article-title":"ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Zuberi","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.jvacx.2024.100558_b0020","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1528-1167.2011.03127.x","article-title":"The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study","volume":"52","author":"O\u2019Callaghan","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jvacx.2024.100558_b0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/epi4.12703","article-title":"Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: a systematic review and meta-analysis","volume":"8","author":"Xu","year":"2023","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.jvacx.2024.100558_b0030","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00006454-199311000-00004","article-title":"Risk of infection during adrenocorticotropic hormone treatment in infants with infantile spasms","volume":"12","author":"Shamir","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jvacx.2024.100558_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107924","article-title":"Risks of ACTH therapy for west syndrome following BCG vaccination","volume":"118","author":"Maki","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jvacx.2024.100558_b0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.braindev.2008.11.007","article-title":"A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome","volume":"31","author":"Ohya","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.jvacx.2024.100558_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpeds.2018.11.042","article-title":"Clinical manifestations, management, and outcomes of osteitis\/osteomyelitis caused by Mycobacterium bovis Bacillus Calmette-Guerin in children: comparison by site(s) of affected bones","volume":"207","author":"Huang","year":"2019","journal-title":"J Pediatr"},{"key":"10.1016\/j.jvacx.2024.100558_b0050","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/apa.15609","article-title":"The sixty-year story of Finnish Bacillus Calmette-Guerin (BCG) osteitis","volume":"110","author":"Korppi","year":"2021","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jvacx.2024.100558_b0055","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies","volume":"133","author":"Marciano","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jvacx.2024.100558_b0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/adc.55.9.664","article-title":"ACTH therapy in infantile spasms: side effects","volume":"55","author":"Riikonen","year":"1980","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jvacx.2024.100558_b0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1651-2227.1986.tb10174.x","article-title":"Impairment of polymorphonuclear leucocyte function during therapy with synthetic ACTH in children affected by epileptic encephalopathies","volume":"75","author":"Colleselli","year":"1986","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.jvacx.2024.100558_b0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2020.10.020","article-title":"SCID newborn screening: what we\u2019ve learned","volume":"147","author":"Currier","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jvacx.2024.100558_b0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/WNL.58.1.110","article-title":"Low-dose ACTH therapy for West syndrome: initial effects and long-term outcome","volume":"58","author":"Ito","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jvacx.2024.100558_b0080","doi-asserted-by":"crossref","unstructured":"Go CY, Mackay MT, Weiss SK, Stephens D, Adams-Webber T, Ashwal S, et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the guideline development subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society. Neurology. 2012;78:1974\u201380. doi: 10.1212\/WNL.0b013e318259e2cf.","DOI":"10.1212\/WNL.0b013e318259e2cf"},{"key":"10.1016\/j.jvacx.2024.100558_b0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/14737175.2023.2216385","article-title":"Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review","volume":"23","author":"Prezioso","year":"2023","journal-title":"Expert Rev Neurother"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T19:29:31Z","timestamp":1729020571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":17,"alternative-id":["S2590136224001311"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100558","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Bacille Calmette-Gu\u00e9rin vaccination on the therapeutic schedule of infantile epileptic spasms syndrome: A 25-year Japanese single-center survey","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100558"}}